STIM

#4003
Neuronetics, Inc. Common Stock
1.42 USD
+2.16%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
1.41
1.43
Range Annuel
0.80
4.82
Changement quotidien
+2.16%
Changement Mensuel
+5.19%
Evolution sur 6 mois
-52.03%
Changement Annuel
-62.63%
Clôture Précédente
1.39
Open
1.42
Bid
Ask
Low
1.41
High
1.43
Volume
74
Open full chart

Financials

Overview Relevé Statistics
Quarterly Annual
  • Market Capitalization 98.37 M
  • Employee 658
  • Founded 2003
  • CEO N/A
  • Website www.neurostar.com
  • Headquarter Delaware, United States
  • FIGI BBG000QX36J1
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.34
Price to sales ratio
0.65

Neuronetics Inc

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device." They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head.

Nouvelles